Tao Synergies Inc. (TAOX) — DEF 14A Filings
All DEF 14A filings from Tao Synergies Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
TAOX Seeks Shareholder Nod for Major Dilutive Financing, Equity Plan Boost
— Nov 17, 2025 Risk: high
TAO Synergies Inc. (TAOX) is holding its 2025 annual meeting virtually on December 18, 2025, to address several critical proposals. The company seeks stockholde -
TAOX Seeks Shareholder Nod for Dilutive Issuance, Equity Plan Boost
— Jul 7, 2025 Risk: high
TAO Synergies Inc. (TAOX) is seeking stockholder authorization for the issuance of common stock underlying convertible preferred stock and warrants, which could -
Synaptogenix Files Proxy Statement for Dec. 6 Meeting
— Nov 7, 2024 Risk: medium
Synaptogenix, Inc. filed its definitive proxy statement on November 7, 2024, for its annual meeting on December 6, 2024. The company, formerly known as Neurotro
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX